Abstract
Human medicines European public assessment report (EPAR): Orbactiv, oritavancin, Soft Tissue Infections,Skin Diseases, Bacterial, Date of authorisation: 18/03/2015, Revision: 7, Status: Authorised
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have